ReviewDiabetes, obesity & metabolism2025

Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonist.

Luděk Horváth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.